Astera Labs, Inc. $ALAB Shares Sold by Teamwork Financial Advisors LLC

Teamwork Financial Advisors LLC lessened its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 37.6% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,959 shares of the company’s stock after selling 2,382 shares during the quarter. Teamwork Financial Advisors LLC’s holdings in Astera Labs were worth $1,912,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in ALAB. Reflection Asset Management purchased a new stake in shares of Astera Labs during the fourth quarter worth about $25,000. CX Institutional raised its position in shares of Astera Labs by 1,330.8% during the 2nd quarter. CX Institutional now owns 186 shares of the company’s stock worth $90,000 after purchasing an additional 173 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares in the last quarter. Wexford Capital LP purchased a new position in Astera Labs in the 3rd quarter valued at about $39,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in Astera Labs in the 4th quarter worth about $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Up 0.8%

NASDAQ ALAB opened at $334.17 on Friday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The business’s fifty day simple moving average is $360.45 and its 200-day simple moving average is $235.27. The firm has a market cap of $57.98 billion, a PE ratio of 165.43, a P/E/G ratio of 3.84 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 1.86 EPS for the current year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research reports. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday. Morgan Stanley lifted their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday. JPMorgan Chase & Co. boosted their price target on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, TD Cowen reduced their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $325.25.

Insider Buying and Selling

In other news, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,244,395 shares of company stock worth $358,865,571 over the last ninety days. 10.40% of the stock is currently owned by insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.